Back to Results
First PageMeta Content
3 / 4-Diaminopyridine / Pyridines / Lambert–Eaton myasthenic syndrome / BioMarin Pharmaceutical / Small-cell carcinoma / NHS Constitution for England / National Health Service / Scottish Medicines Consortium / Medicine / Health / Paraneoplastic syndromes


Clinical Commissioning Policy Statement: Amifampridine (Firdapse) for Lambert Easton Myasthenic Syndrome (LEMS) April 2013
Add to Reading List

Document Date: 2014-08-12 08:05:40


Open Document

File Size: 449,89 KB

Share Result on Facebook
UPDATE